Table 1.

Characteristics of patients

Characteristic	Total (n=23)
Age, years, median (range)	47 (20–66)
Male, %	78.3
Comorbidities, %
Diabetes	13
Chronic kidney disease	4.3
Chronic obstructive pulmonary disease	8.7
Cirrhosis	13
Autoimmune diseases, %
Psoriatic arthritis	30.4
Psoriasis	13
Rheumatoid arthritis	17.4
Ankylosing Spondylitis	8.7
Inflammatory arthritis	8.7
Ulcerative colitis	8.7
Reactive arthritis	4.3
Sjogren’s neuropathy	4.3
Undifferentiated spondyloarthropathy	4.3
Immunosuppression, %
Glucocorticoids, any dose	39.1
≥ 10 mg prednisone/day	26
Conventional therapy	30.4
Methotrexate	26
6-Mercaptopurine	4.3
TNF-α inhibitor therapy, %
Etanercept	61.5
Adalimumab	23.1
Infliximab	15.4
HIV parameters
cART, %	95.7
CD4 nadir, cells/mm3	210 (7–1096)
CD4 at initiation, cells/mm3	541.5 (1–1100)
Viral load at TNF-α inhibitor initiation, copies/mL	Undetectable (Undetectable to 500,000)

TNF = tumor necrosis factor; cART = combination antiretroviral therapy.